Schoen SR - Search Results

1

Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor.

Li Z, Wang D, Na X, Schoen SR, Messing EM, Wu G. Li Z, et al. Among authors: schoen sr. Biochem Biophys Res Commun. 2002 Jun 14;294(3):700-9. doi: 10.1016/S0006-291X(02)00534-X. Biochem Biophys Res Commun. 2002. PMID: 12056827

2

Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.

Li Z, Na X, Wang D, Schoen SR, Messing EM, Wu G. Li Z, et al. Among authors: schoen sr. J Biol Chem. 2002 Feb 15;277(7):4656-62. doi: 10.1074/jbc.M108269200. Epub 2001 Dec 5. J Biol Chem. 2002. PMID: 11739384 Free article.

3

The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity.

Li Z, Wang D, Na X, Schoen SR, Messing EM, Wu G. Li Z, et al. Among authors: schoen sr. EMBO J. 2003 Apr 15;22(8):1857-67. doi: 10.1093/emboj/cdg173. EMBO J. 2003. PMID: 12682018 Free PMC article.

4

Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.

Na X, Wu G, Ryan CK, Schoen SR, di'Santagnese PA, Messing EM. Na X, et al. Among authors: schoen sr. J Urol. 2003 Aug;170(2 Pt 1):588-92. doi: 10.1097/01.ju.0000074870.54671.98. J Urol. 2003. PMID: 12853836

5

Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.

Na X, Duan HO, Messing EM, Schoen SR, Ryan CK, di Sant'Agnese PA, Golemis EA, Wu G. Na X, et al. Among authors: schoen sr. EMBO J. 2003 Aug 15;22(16):4249-59. doi: 10.1093/emboj/cdg410. EMBO J. 2003. PMID: 12912922 Free PMC article.

6

A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling.

Wang D, Li Z, Schoen SR, Messing EM, Wu G. Wang D, et al. Among authors: schoen sr. Biochem Biophys Res Commun. 2004 Jan 9;313(2):320-6. doi: 10.1016/j.bbrc.2003.11.124. Biochem Biophys Res Commun. 2004. PMID: 14684163

7

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression.

Wu M, Si S, Li Y, Schoen S, Xiao GQ, Li X, Teh BT, Wu G, Chen J. Wu M, et al. Oncotarget. 2015 Oct 20;6(32):32761-73. doi: 10.18632/oncotarget.5018. Oncotarget. 2015. PMID: 26418749 Free PMC article.

8

Calcitonin receptor mRNA expression in the human prostate.

Wu G, Burzon DT, di Sant'Agnese PA, Schoen S, Deftos LJ, Gershagen S, Cockett AT. Wu G, et al. Urology. 1996 Mar;47(3):376-81. doi: 10.1016/s0090-4295(99)80456-7. Urology. 1996. PMID: 8633405 Free article.

9

Folliculin deficient renal cancer cells show higher radiosensitivity through autophagic cell death.

Zhang Q, Si S, Schoen S, Jin XB, Chen J, Wu G. Zhang Q, et al. J Urol. 2014 Jun;191(6):1880-8. doi: 10.1016/j.juro.2014.01.001. Epub 2014 Jan 13. J Urol. 2014. PMID: 24434776

10

Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells.

Zhang Q, Si S, Schoen S, Chen J, Jin XB, Wu G. Zhang Q, et al. J Exp Clin Cancer Res. 2013 Dec 4;32(1):99. doi: 10.1186/1756-9966-32-99. J Exp Clin Cancer Res. 2013. PMID: 24305604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters